Physician profile
Ryan Velasquez
NPI 1063262657
$2,348.10
in general payments reported to CMS, 2019-2025
16 companies · $1,489 in 2025
The $1,489 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $859 · 2025: $1,489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,259 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,259.11 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $375.02 | 2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $360.85 | 2024-2025 | Ofev |
| Abbvie INC. | $337.13 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $259.43 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Electromed, INC. | $236.08 | 2024-2025 | Smartvest |
| Verona Pharma, INC. | $171.01 | 2025 | Ohtuvayre |
| Insmed, INC. | $137.72 | 2025 | Arikayce |
| Gilead Sciences, INC. | $116.71 | 2024 | Livdelzi |
| Mallinckrodt Hospital Products INC. | $72.89 | 2024-2025 | Acthar |
| Merck Sharp & Dohme LLC | $63.82 | 2025 | Zerbaxa |
| Grifols USA, LLC | $57.83 | 2024-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $55.43 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Regeneron Healthcare Solutions, INC. | $44.88 | 2024 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $24.25 | 2025 | Airsupra |
| Viatris Specialty LLC | $19.17 | 2025 | Yupelri |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.88 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Velasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.